Xylem Inc. (NYSE:XYL - Get Free Report) saw a significant decline in short interest in March. As of March 15th, there was short interest totalling 2,990,000 shares, a decline of 12.3% from the February 28th total of 3,410,000 shares. Based on an average trading volume of 1,420,000 shares, the short-interest ratio is currently 2.1 days. Approximately 1.2% of the shares of the stock are short sold.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on XYL shares. Wolfe Research restated a "peer perform" rating on shares of Xylem in a research note on Thursday, December 12th. Robert W. Baird boosted their price target on shares of Xylem from $139.00 to $148.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 5th. Citigroup downgraded shares of Xylem from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 5th. Finally, Stifel Nicolaus reduced their target price on Xylem from $166.00 to $150.00 and set a "buy" rating on the stock in a research note on Friday, January 24th. Four equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, Xylem currently has an average rating of "Moderate Buy" and an average target price of $149.89.
Read Our Latest Stock Report on XYL
Xylem Trading Down 6.8 %
Shares of NYSE:XYL traded down $8.11 during trading on Thursday, reaching $110.94. 2,755,583 shares of the company traded hands, compared to its average volume of 1,328,899. The company has a current ratio of 1.76, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. Xylem has a 52-week low of $110.90 and a 52-week high of $146.08. The firm has a market capitalization of $26.96 billion, a price-to-earnings ratio of 30.31, a P/E/G ratio of 2.33 and a beta of 1.08. The business's fifty day moving average is $125.38 and its 200-day moving average is $125.54.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share for the quarter, beating the consensus estimate of $1.12 by $0.06. The business had revenue of $2.30 billion during the quarter, compared to analysts' expectations of $2.18 billion. Xylem had a net margin of 10.40% and a return on equity of 9.96%. The firm's revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.99 EPS. As a group, analysts forecast that Xylem will post 4.65 EPS for the current year.
Xylem Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Investors of record on Tuesday, February 18th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Tuesday, February 18th. This is a positive change from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a dividend yield of 1.44%. Xylem's payout ratio is currently 43.72%.
Institutional Investors Weigh In On Xylem
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in shares of Xylem by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 28,644,417 shares of the industrial products company's stock valued at $3,323,325,000 after buying an additional 303,854 shares during the last quarter. State Street Corp lifted its position in Xylem by 1.9% in the 3rd quarter. State Street Corp now owns 10,329,494 shares of the industrial products company's stock valued at $1,394,792,000 after acquiring an additional 189,820 shares in the last quarter. Geode Capital Management LLC boosted its stake in Xylem by 2.4% during the 4th quarter. Geode Capital Management LLC now owns 5,804,247 shares of the industrial products company's stock valued at $671,623,000 after purchasing an additional 135,492 shares during the last quarter. Impax Asset Management Group plc increased its holdings in shares of Xylem by 231.5% in the 4th quarter. Impax Asset Management Group plc now owns 5,561,661 shares of the industrial products company's stock worth $644,039,000 after purchasing an additional 3,883,845 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of Xylem by 7.9% in the 4th quarter. Royal Bank of Canada now owns 4,369,804 shares of the industrial products company's stock worth $506,985,000 after purchasing an additional 320,500 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
About Xylem
(
Get Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.